Ranganath, L. R., Milan, A. M., Hughes, A. T., Dutton, J. J., Fitzgerald, R., Briggs, M. C., Bygott, H., Psarelli, E. E., Cox, T. F., Gallagher, J. A., Jarvis, J. C., van Kan, C., Hall, A. K., Laan, D., Olsson, B., Szamosi, J., Rudebeck, M., Kullenberg, T., Cronlund, A., Svensson, L., Junestrand, C., Ayoob, H., Timmis, O. G., Sireau, N., Le Quan Sang, K., Genovese, F., Braconi, D., Santucci, A., Nemethova, M., Zatkova, A., McCaffrey, J., Christensen, P., Ross, G., Imrich, R., & Rovensky, J. (2016). suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment. Annals of the rheumatic diseases, 75(2), 362–367. http://access.bl.uk/ark:/81055/vdc_100137794417.0x000061